Results 41 to 50 of about 49,882 (160)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy

Journal of Veterinary Internal Medicine, 2022
Background Activity of the circulating renin‐angiotensin‐aldosterone system (RAAS) has not been comprehensively characterized in cats with systemic hypertension (SH) or cardiomyopathy (CM), and the effects of furosemide or amlodipine treatment on the ...
Jessica L. Ward, Emilie Guillot, Oliver Domenig, Wendy A. Ware, Lingnan Yuan, Jonathan P. Mochel   +5 more
doaj   +1 more source

Effect of Furosemide on Urinary Oxygenation in Patients with Septic Shock. [PDF]

, 2019
BACKGROUND Renal medullary hypoxia precedes the development of acute kidney injury in experimental sepsis and can now be assessed by continuous measurement of urinary oxygen tension (PuO2).
Cutuli, Salvatore Lucio, May, Clive N., Evans, Roger G., May, Clive N, Lankadeva, Yugeesh R., Lankadeva, Yugeesh R, Cioccari, Luca, Osawa, Eduardo Atsushi, Iguchi, Naoya, Canet, Emmanuel, Eastwood, Glenn M, Bellomo, Rinaldo, Eastwood, Glenn M., Evans, Roger G, Bitker, Laurent   +14 more
core   +1 more source

Simultaneous Determination of Sulfanilamide and Furosemide by Using Derivative Spectrophotometry

Ibn Al-Haitham Journal for Pure and Applied Sciences, 2017
A simple, precise and accurate spectrophotometric method has been developed for simultaneous estimation of sulfanilamide and furosemide in their mixture by using first and second order derivative method in the ultraviolet region.
Samar A. Darweesh
doaj  

Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left‐sided congestive heart failure in dogs

Journal of Veterinary Internal Medicine, 2022
Background Kidney injury (KI) has been documented in dogs treated with furosemide for left‐sided congestive heart failure (CHF). Hypothesis/Objectives Determine risk factors for development of KI in furosemide‐treated dogs and determine the effect of KI ...
Maria E. Giorgi, Jonathan P. Mochel, Lingnan Yuan, Darcy B. Adin, Jessica L. Ward   +4 more
doaj   +1 more source

Furosemide prevention VS treatment subgroup.

, 2018
Furosemide prevention VS treatment subgroup.
Tiziana Bove (5136128), Giovanni Landoni (504703), Alberto Zangrillo (504705), Alessandro Putzu (3570173), Sean M. Bagshaw (402830), Alessandro Belletti (504879), Simone Pappacena (5136134), Giuseppe Denaro (5136131)   +7 more
core   +1 more source

Biotransformation of furosemide in kidney transplant patients [PDF]

, 1983
The metabolic fate of furosemide was studied in kidney transplant patients after oral and intravenous administration of the diuretic at therapeutic doses.
Benet, Leslie Z., Smith, David E.
core   +1 more source

Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study

BMC Cancer, 2019
Background Pre-clinical studies have shown that furosemide slows cancer cell growth by acting on the Na-K-2Cl transporter, particularly for gastric cancer cells.
Peipei Liu, Úna C. McMenamin, Andrew D. Spence, Brian T. Johnston, Helen G. Coleman, Chris R. Cardwell   +5 more
doaj   +1 more source

Serum chloride and serum sodium derangements in children on prolonged furosemide therapy and their effect on diuretic response

Egyptian Pediatric Association Gazette, 2022
Background Electrolyte disturbances are not uncommon in patients on chronic furosemide therapy. We hypothesized that serum chloride (Cl) and serum sodium (Na) abnormalities may occur in children on prolonged furosemide therapy affecting the diuretic ...
Nanies Mohamed Salah EL Din Soliman, Alyaa Amal Kotby, Menatallah Ali Shabaan, Esraa Matarawy Eid   +3 more
doaj   +1 more source

Does furosemide increase oxidative stress in acute kidney injury?

, 2017
Furosemide, a loop diuretic, is used to increase urine output in patients with acute kidney injury (AKI). It remains uncertain whether the benefits of furosemide in AKI outweigh its potential harms.
Corcoran, Tomas B., Mori, T.A., Barden, Anne E., Morgan, D.J., Lipman, J., Silbert, B. I., Pavey, W., Mas, E., Silbert, Benjamin I., Lipman, Jeffrey, Morgan, David J., Mori, Trevor A., Ho, Kwok M., Barden, A.E., Pavey, Warren, Roberts, J.A., Mas, Emilie, Ho, K.M., Roberts, Jason A., Corcoran, T.B.   +19 more
core   +1 more source

Inhibitory effect of furosemide on histamine release from human basophils [PDF]

, 1992
furosemideは利尿剤として知られているが,吸入することにより気道収縮に対して抑制的に作用することが近年報告されている｡その抑制作用の機序を明らかにする目的で,furosemide添加による末梢血好塩基球からのヒスタミン遊離に対する抑制効果を検討した｡健常人4例,アトピー型気管支喘息患者8例を対象として全血法で抗ヒトIgE刺激によるヒスタミン遊離を観察した｡なお,furosemideの最終濃度は0,1,10,100μg/mlに調整して添加実験を行った｡健常人,気管支喘息いずれにおいても ...
Tanizaki, Yoshiro, Okazaki, Morihiro, Kitani, Hikaru, Kusaura, Yasuhiro, Tanimizu, Masakuni, Mitsunobu, Fumihiro, Mifune, Takashi, Honke, Naoko   +7 more
core   +1 more source